NAD+
A naturally occurring coenzyme studied in cellular energy and aging research.
Research Use Only — Not for Human ConsumptionShort Description
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell, central to energy metabolism and DNA repair. Injectable and IV NAD+ products have become popular in wellness settings, and it is an active area of academic research into aging and metabolic health.
Current Legal Status (Mauritius)
Tiger Blood Pharmaceuticals is pursuing product registration in the Republic of Mauritius, where pharmaceutical products are regulated by the Pharmacy Board, operating under the Ministry of Health and Wellness pursuant to the Pharmacy Act 1983. NAD+ is not currently registered as a pharmaceutical product in Mauritius, and our registration application has not yet been completed. Until registration is granted, NAD+ is supplied strictly for laboratory research use and is not sold, marketed or labeled as a medicine, supplement or treatment for any condition in any jurisdiction.
Tiger Blood Pharmaceuticals does not hold regulatory approval for NAD+ in the United States, the European Union, the United Kingdom, or any other jurisdiction. Because this website is publicly accessible, customers are responsible for confirming that the purchase, import and use of this product is lawful where they live before placing an order.
This page will be updated once our Mauritius registration status changes.
Research Evidence
A substantial body of basic-science research links NAD+ to cellular energy production and age-related decline, but this is largely laboratory and animal work. Human clinical evidence for injectable or IV NAD+ products, as sold commercially, remains limited, and regulators including the FDA have raised questions about the compounding of NAD+ products for human use.